| 03-20 09:47
|
methyl N-[(E)-5-[(5E)-5-[(2E,4E,9Z,13E)-1,8-dihydroxy-2,5,9-trimethylpentadeca-2,4,9,13-tetraenylidene]-4,6-dioxopyran-2-yl]hex-1-enyl]carbamate 93195-32-5
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/100mg,500mg,1g,5g
|
¥Inquiry/100mg
¥Inquiry/500mg
¥Inquiry/1g
¥Inquiry/5g
|
|
| 03-20 09:47
|
7,13,17,29,33-Pentaoxa-34,35-diazatetracyclo[29.2.1.115,18.06,8]pentatriaconta-1(34),2,4,9,15,18(35),21,23,25,31-decaene-14,30-dione, 12,28-bis[(2S,3E)-2-hydroxy-1,1-dimethyl-3-penten-1-yl]-20-methoxy-, (2Z,4E,6S,8R,9Z,12S,20R,21E,23Z,25Z,28S) 158181-47-6
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/100mg,500mg,1g,5g
|
¥Inquiry/100mg
¥Inquiry/500mg
¥Inquiry/1g
¥Inquiry/5g
|
|
| 03-20 09:47
|
(E,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8-methyl-N-[(3S)-2-oxoazepan-3-yl]non-6-enamide 118477-03-5
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/100mg,500mg,1g,5g
|
¥Inquiry/100mg
¥Inquiry/500mg
¥Inquiry/1g
¥Inquiry/5g
|
|
| 03-20 09:47
|
Ambruticin 58857-02-6
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
95.0% |
Inquiry/500mg,1g,5g
|
¥Inquiry/500mg
¥Inquiry/1g
¥Inquiry/5g
|
|
| 03-20 09:47
|
Tubulysin 1943604-24-7
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/500mg,1g,5g
|
¥Inquiry/500mg
¥Inquiry/1g
¥Inquiry/5g
|
|
| 03-20 09:47
|
CL2A-SN-38 1279680-68-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
CL2-SN-38 1036969-20-6
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
maytansine 35846-53-8
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
N-Me-L-Ala-maytansinol 77668-69-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
MC-DM1 1375089-56-7
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
Lipoxamycin hemisulfate 11075-87-9
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
eIF4A3-IN-1 2095486-67-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
SHP389 2235394-90-6
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
N-{5-[(E)-3-Furan-2-yl-prop-2-en-(Z)-ylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-benzenesulfonamide 1815598-71-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
Pactimibe sulfate 608510-47-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
MRK-016 342652-67-9
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
2-Hydroxy-4-[(4-{(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}butanoyl)amino]benzoic acid 1164500-72-4
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
GnRH antagonist 2 1709823-61-9
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
CP-547632 hydrochloride 252003-71-7
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|
| 03-20 09:47
|
NX-13 2389235-01-0
|
Changsha Fuzhen Biotechnology Co., Ltd. China
|
98.0% |
Inquiry/5g,10g
|
¥Inquiry/5g
¥Inquiry/10g
|
|